Global Group A and Group C Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2023-2029

Global Group A and Group C Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2023-2029

The global Group A and Group C Meningococcal Polysaccharide Vaccine market size is expected to reach $ 430.2 million by 2029, rising at a market growth of 5.6% CAGR during the forecast period (2023-2029).

Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.

After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.

This report studies the global Group A and Group C Meningococcal Polysaccharide Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Group A and Group C Meningococcal Polysaccharide Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Group A and Group C Meningococcal Polysaccharide Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Group A and Group C Meningococcal Polysaccharide Vaccine total production and demand, 2018-2029, (K Units)

Global Group A and Group C Meningococcal Polysaccharide Vaccine total production value, 2018-2029, (USD Million)

Global Group A and Group C Meningococcal Polysaccharide Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Group A and Group C Meningococcal Polysaccharide Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Group A and Group C Meningococcal Polysaccharide Vaccine domestic production, consumption, key domestic manufacturers and share

Global Group A and Group C Meningococcal Polysaccharide Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Group A and Group C Meningococcal Polysaccharide Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Group A and Group C Meningococcal Polysaccharide Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Group A and Group C Meningococcal Polysaccharide Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Walvax, Lanzhou Institute of Biological Products, AIM Bio, Sanofi Pasteur, GSK, Hualan Bio, ZFSW, Changsheng and Kanghua Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Group A and Group C Meningococcal Polysaccharide Vaccine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, Segmentation by Type
Class 1 Vaccine
Class II Vaccine

Global Group A and Group C Meningococcal Polysaccharide Vaccine Market, Segmentation by Application
Hospital
Clinic

Companies Profiled:
Walvax
Lanzhou Institute of Biological Products
AIM Bio
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Changsheng
Kanghua Bio

Key Questions Answered

1. How big is the global Group A and Group C Meningococcal Polysaccharide Vaccine market?

2. What is the demand of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?

3. What is the year over year growth of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?

4. What is the production and production value of the global Group A and Group C Meningococcal Polysaccharide Vaccine market?

5. Who are the key producers in the global Group A and Group C Meningococcal Polysaccharide Vaccine market?

6. What are the growth factors driving the market demand?